Azitra (NYSEAMERICAN:AZTR) Trading Up 14% – Should You Buy?

Azitra, Inc. (NYSEAMERICAN:AZTR)’s stock price traded up 14% during trading on Friday . The company traded as high as $0.47 and last traded at $0.46. 1,572,722 shares were traded during mid-day trading, an increase of 94% from the average session volume of 809,416 shares. The stock had previously closed at $0.41.

Azitra Trading Up 14.0 %

Azitra (NYSEAMERICAN:AZTR) last announced its earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.48) by $0.31. Sell-side analysts anticipate that Azitra, Inc. will post -2.78 earnings per share for the current fiscal year.

About Azitra

Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.